Results 91 to 100 of about 44,865 (239)

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. [PDF]

open access: yes, 2012
Drug resistance presents a challenge to the treatment of cancer patients. Many studies have focused on cell-autonomous mechanisms of drug resistance. By contrast, we proposed that the tumour micro-environment confers innate resistance to therapy. Here we
Barzily-Rokni, Michal   +18 more
core   +1 more source

Can mutation abundance assess the biological behavior of BRAF V600E-positive papillary thyroid carcinoma?

open access: yesJournal of Translational Medicine
Background BRAF V600E mutation is the most common genetic change in papillary thyroid carcinoma (PTC). Nevertheless, the association between BRAF V600E mutation status and abundance and the biological behavior of PTC is unclear.
Yeqin Ni   +31 more
doaj   +1 more source

Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging

open access: yesBMC Cancer
Objectives Seeking a noninvasive predictor for BRAF V600E mutation status of pleomorphic xanthoastrocytomas (PXAs) is essential for their prognoses and therapeutic use of BRAF inhibitors.
Jing Yan   +9 more
doaj   +1 more source

Presence of BRAF V600E Mutation in Nevus Cases

open access: yesTurkiye Klinikleri Journal of Medical Sciences, 2010
V-raf murine sarcoma viral oncogene homolog B1 (BRAF), belongs to the family of V-RAF-1 murine leukemia viral oncogene homolog 1 (RAF) gene located in the long arm of chromosome 7 (7q34). The BRAF gene encodes a protein that has function in mitogen activated protein kinase (MAPK) signaling pathway with serin/threonin kinase activity.
Çetin, Ayşen   +5 more
openaire   +5 more sources

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma. [PDF]

open access: yes, 2018
Despite major advances in targeted melanoma therapies, drug resistance limits their efficacy. Long noncoding RNAs (lncRNAs) are transcriptome elements that do not encode proteins but are important regulatory molecules.
Burlingame, Alma   +18 more
core   +1 more source

Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst

open access: yesOral Oncology, 2017
Odontogenic keratocyst (OKC), also known as keratocystic odontogenic tumor (KCOT), has clinical significance due to its high incidence as well as high recurrence rate after surgical enucleation. Current clinical management for OCK is entirely dependent on surgical approach.
Yong Hoon Cha   +9 more
openaire   +3 more sources

Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection

open access: yesCancer Science, EarlyView.
Urinary EVs provide highly pure vesicles with superior DNA quality, making them a robust and completely non‐invasive source for molecular profiling. Urinary EV‐DNA–based MRD assessment shows significant prognostic value and may serve as a practical tool for postoperative monitoring and risk stratification in colorectal cancer.
Shintaro Kanaka   +14 more
wiley   +1 more source

MicroRNA-203 predicts human survival after resection of colorectal liver metastasis. [PDF]

open access: yes, 2016
BackgroundResection of colorectal liver metastasis (CRLM) can be curative. Predicting which patients may benefit from resection, however, remains challenging. Some microRNAs (miRNAs) become deregulated in cancers and contribute to cancer progression.
D'Angelica, Michael I   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy